Table 1:
Demographics for controls and patients
| Subject | Status | Age (yr)/Sex | Disease Duration (yr) | Psychotropic Medication |
|---|---|---|---|---|
| 1 | C | 45/M | NA | NA |
| 2 | C | 31/M | NA | NA |
| 3 | C | 29/F | NA | NA |
| 4 | C | 36/M | NA | NA |
| 5 | C | 43/M | NA | NA |
| 6 | C | 24/F | NA | NA |
| 7 | C | 55/F | NA | NA |
| 8 | C | 26/F | NA | NA |
| 9 | C | 29/F | NA | NA |
| 10 | C | 22/M | NA | NA |
| 11 | C | 31/F | NA | NA |
| 12 | P | 41/M | 22 | Fluphenazine |
| 13 | P | 44/F | 27 | Quetiapine |
| 14 | P | 43/M | 18 | Haloperidol, quetiapine |
| 15 | P | 52/M | 32 | Citalopram |
| 16 | P | 51/F | 15 | Gabapentin, lithium, ziprasidone |
| 17 | P | 23/M | 3 | Risperidone |
| 18 | P | 47/M | 31 | Fluoxetine, risperidone, valproic acid, trazodone |
| 19 | P | 44/M | 26 | Clozapine, valproic acid |
| 20 | P | 26/M | 8 | Ziprasidone |
| 21 | P | 29/F | 8 | Bupropion, aripiprazole, fluphenazine |
| 22 | P | 42/F | 23 | Ziprasidone, bupropion, eszopiclone |
| 23 | P | 22/M | 4 | Clozapine |
| 24 | P | 48/M | 23 | Quetiapine |
| 25 | P | 34/M | 5 | Risperidone |
| 26 | P | 30/F | 10 | Risperidone |
| 27 | P | 49/F | 31 | Aripiprazole |
| 28 | P | 51/F | 35 | NA |
| 29 | P | 43/F | 20 | Aripiprazole, escitalopram, fluphenazine |
| 30 | P | 52/M | 30 | Aripiprazole, valproic acid, hydroxyzine, paroxetine, trazodone |
Note:—NA indicates not applicable; C, controls; P, patients.